Beijing Do-Care Biotech

Beijing Do-Care Biotech is a specialized biotechnology company headquartered in Beijing, China, focusing on the development and manufacture of in vitro diagnostic (IVD) solutions. The company primarily operates in the Point-of-Care Testing (POCT) sector, providing rapid quantitative detection systems for clinical use. Their core technology utilizes a fluorescence immunochromatography platform to analyze biomarkers related to cardiovascular disease, inflammation, and infectious conditions. Do-Care Biotech's product portfolio includes automated analyzers and a wide range of test kits for markers such as NT-proBNP, Cardiac Troponin I, and Procalcitonin. The company maintains high quality standards with ISO 13485 certification and GMP-compliant manufacturing facilities. By integrating research, production, and sales, Beijing Do-Care Biotech supports healthcare providers in delivering timely and accurate diagnostic information for emergency and critical care.